Irina Pahlevanyan: Global Leaders on Courage, Trust, and the True Purpose of Fundraising
Irina Pahlevanyan, Vice President of the Executive Board and Chair of the Corporate Sustainability Commission at ICC National Committee Armenia, Executive Director at 4090 Charity Foundation, shared a post on LinkedIn:
“Some conversations remind us why we do what we do!
In this powerful exchange between Her Royal Highness Princess Dina Mired and Dr. Gevorg Tamamyan, two remarkable global leaders speak openly about the importance of asking for support when it is for the wellbeing of others.
It is a powerful reminder that fundraising is never about money itself. It is about courage, trust, and the willingness to stand between vulnerability and opportunity.
It is about opening doors for those who cannot open them alone. It is about making impact, creating chances, protecting futures, and sometimes even saving lives.
Moments like this remind me why fundraising is not just a profession, it is a mission.
By the way, if you would like to listen to the full episode, which is full of deep insights and meaningful reflections.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS